Posts by: Ines Martins, PhD

Ines Martins, PhD

Inês Martins holds a BSc in Cell and Molecular Biology from Universidade Nova de Lisboa and is currently finishing her PhD in Biomedical Sciences at Universidade de Lisboa. Her work has been focused on blood vessels and their role in both hematopoiesis and cancer development.

June 28, 2016June 28, 2016

Peptide to Treat Drug-Resistant Pneumonias Being Developed in Europe

SetLance SRL announced that its antimicrobial peptide M33, being developed for people with difficult-to-treat lung infections like pneumonia, is robust enough for industrial production. Standard treatment for these patients is an intravenous administration of ... Read more

June 8, 2016

Chlamydia Not a Common Agent of Community-Acquired Pneumonia, Researchers Say

Researchers investigated Chlamydia infections in patients with community-acquired pneumonia and the findings suggest that the role of these infections may be overestimated, with other types of bacteria likely causing the disease. ... Read more

May 25, 2016May 25, 2016

NIH Awards $3M to Develop Way of Using Gene Therapy to Treat Respiratory Distress Syndrome

Researchers at the University of Rocherster Medical Center (URMC) have received a $3 million, four-year grant to develop a means of gene therapy delivery that might treat patients with acute respiratory distress syndrome ... Read more

May 19, 2016May 19, 2016

Bayer Terminates Riociguat Trial for PH Associated with Idiopathic Interstitial Pneumonias Due to Adverse Events

Bayer recently announced that the company will immediately terminate its Phase 2 clinical trial of riociguat in patients with pulmonary hypertension associated with idiopathic interstitial pneumonias (PH-IIP), following the recommendation of an independent Data Monitoring ... Read more

May 16, 2016May 16, 2016

New Study Emphasizes Importance of Pneumonia Vaccine in Celiac Disease Patients

Patients with celiac disease who did not receive the pneumococcal vaccine are at high risk of getting pneumonia, according to the study, “The risk of community acquired pneumonia among 9,803 patients with ... Read more

May 5, 2016May 6, 2016

Quick and Easy Molecular Test for Mycoplasma pneumoniae Approved for European Use

Meridian Bioscience announced that the company’s new, simplified, and rapid molecular diagnostic test for Mycoplasma pneumoniae has received the CE Mark, allowing for the product to be legally placed on the European ... Read more